PHF6 mutation is associated with poor outcome in acute myeloid leukaemia.

Kexiu HuangLei WangYaling ZhengChunyan YueXuedan XuHongbo ChenRui Huang Yu-Hua Li

Published in: Cancer medicine (2022)

Our data revealed that PHF6 mutation was associated with a lower chemotherapy response and shorter survival, suggesting that PHF6 mutation is a predictor of poor prognosis in AML.

Keyphrases

poor prognosis
long non coding rna
acute myeloid leukemia
liver failure
bone marrow
electronic health record
respiratory failure
squamous cell carcinoma
machine learning
drug induced
allogeneic hematopoietic stem cell transplantation
aortic dissection
rectal cancer